請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66115
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 楊銘欽 | |
dc.contributor.author | Tsai-Han Liao | en |
dc.contributor.author | 廖彩涵 | zh_TW |
dc.date.accessioned | 2021-06-17T00:22:18Z | - |
dc.date.available | 2015-09-17 | |
dc.date.copyright | 2012-09-17 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2012-06-13 | |
dc.identifier.citation | 23-valent pneumococcal polysaccharide vaccine. WHO position paper. (2008). Wkly Epidemiol Rec, 83(42), 373-384.
Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical infectious diseases, 15(1), 77. Bishai, D., Brice, R., Girod, I., Saleh, A., & Ehreth, J. (2007). Conjoint Analysis of French and German Parents Willingness to Pay for Meningococcal Vaccine. Pharmacoeconomics, 25(2), 143-154. Bridy-Pappas, A. E., Margolis, M. B., Center, K. J., & Isaacman, D. J. (2005). Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention. Pharmacotherapy, 25(9), 1193-1212. Brown, D. S., Johnson, F. R., Poulos, C., & Messonnier, M. L. (2010). Mothers' preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine, 28(7), 1702-1708. Chen, M. F., Wang, R. H., Schneider, J. K., Tsai, C. T., Jiang, D. D. S., Hung, M. N., et al. (2011). Using the Health Belief Model to Understand Caregiver Factors Influencing Childhood Influenza Vaccinations. Journal of Community Health Nursing, 28(1), 29-40. Chiou, C. C. C., Liu, Y. C., Huang, T. S., Hwang, W. K., Wang, J. H., Lin, H. H., et al. (1998). Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. Journal of clinical microbiology, 36(7), 1933. Chiu, C. H., Su, L. H., Huang, Y. C., Lai, J. C., Chen, H. L., Wu, T. L., et al. (2007). Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae in Taiwan. Antimicrobial agents and chemotherapy, AAC. 01563-01506v01561. Chuang, S. Y., Yen, C. C., Wu, J. S., Huang, C. C., Chiang, C. S., Cheng, X. W., et al. (2009). The Surveillance and Epidemiological Analysis of Streptococcus Pneumoniae Infection, Category Four Communicable Disease, in Taiwan. Epidemiology Bulletin, 25(1), 4-20. Dahlstrom, L. A., Tran, T. N., Lundholm, C., Young, C., Sundstrom, K., & Sparen, P. (2010). Attitudes to HPV vaccination among parents of children aged 12 15 years!XA population based survey in Sweden. International Journal of Cancer, 126(2), 500-507. DeVellis, R. F. (1991). Scale Development. Theory and Applications. Applied Social Research Methods Series, Vol 26. Neybury Park: Sage. Gundogdu, Z., & Gundogdu, O. (2011). Parental attitudes and varicella vaccine in Kocaeli, Turkey. Prev Med, 52(3-4), 278-280. Henrichsen, J. (1995). Six newly recognized types of Streptococcus pneumoniae. Journal of clinical microbiology, 33(10), 2759. Hsueh, P. R., & Luh, K. T. (2002). Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerging Infectious Diseases, 8(12), 1487. Hsueh, P. R., Teng, L. J., Lee, L. N., Yang, P. C., Ho, S. W., & Luh, K. T. (1999). Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. Journal of clinical microbiology, 37(4), 897. Janz, N. K., & Becker, M. H. (1984). The health belief model: a decade later. Health Education & Behavior, 11(1), 1. Jean, S. S., Hsueh, P. R., Lee, W. S., Chang, H. T., Chou, M. Y., Chen, I. S., et al. (2009). Nationwide surveillance of antimicrobial resistance among Haemophilus influenzae and Streptococcus pneumoniae in intensive care units in Taiwan. European Journal of Clinical Microbiology & Infectious Diseases, 28(8), 1013-1017. Johannesson, M. (1996). Theory and methods of economic evaluation of health care: Springer. Klose, T. (1999). The contingent valuation method in health care. Health Policy, 47(2), 97-123. Kyaw, M. H., Lynfield, R., Schaffner, W., Craig, A. S., Hadler, J., Reingold, A., et al. (2006). Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine, 354(14), 1455-1463. Liao, C. H., Liu, J. T., Pwu, R. F., You, S. L., Chow, I., & Tang, C. H. (2009). Valuation of the Economic Benefits of Human Papillomavirus Vaccine in Taiwan. Value in Health, 12, S74-S77. Liu, J. T., Hammitt, J. K., Wang, J. D., & Liu, J. L. (2000). Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan. Health Econ, 9(4), 319-326. Liu, J. T., Hammitt, J. K., Wang, J. D., & Tsou, M. W. (2005). Valuation of the risk of SARS in Taiwan. Health Econ, 14(1), 83-91. Lynch III, J. P., & Zhanel, G. G. (2010). Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Current opinion in pulmonary medicine, 16(3), 217. Maiman, L. A., & Becker, M. H. (1974). The health belief model: Origins and correlates in psychological theory. Health education monographs, 2(4), 336-353. MEYERHOFF, A. S., WENIGER, B. G., & Jacobs, R. (2001). Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections. The Pediatric infectious disease journal, 20(11), S57. Nowalk, M. P., Lin, C. J., Zimmerman, R. K., Ko, F. S., Hoberman, A., Zoffel, L., et al. (2007). Changes in parents' perceptions of infant influenza vaccination over two years. J Natl Med Assoc, 99(6), 636-641. O'Brien, B., & Gafni, A. (1996). When Do the' Dollars' Make Sense? Medical Decision Making, 16(3), 288. Olsen, J. A., & Smith, R. D. (2001). Theory versus practice: a review of 'willingness-to-pay' in health and health care. Health Econ, 10(1), 39-52. Painter, J. E., Sales, J. M., Pazol, K., Wingood, G. M., Windle, M., Orenstein, W. A., et al. (2010). Psychosocial correlates of intention to receive an influenza vaccination among rural adolescents. Health education research, 25(5), 853. Petersen, K. D., Gyrd-Hansen, D., Linneberg, A., Dahl, R., Larsen, J. N., Lowenstein, H., et al. (2010). Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy. International journal of technology assessment in health care, 26(01), 20-29. Petty, T. J., Callahan, S. T., Chen, Q., Edwards, K. M., & Dempsey, A. F. (2010). Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females. Vaccine, 28(35), 5686-5690. Ping-Ing Lee, C.-H. C., Po-Yen Chen, Chin-Yun Lee, Tzou-Yien Lin. (2007). Guideline on the Management of Community-Acquired Pneumonia in Children. Acta Paediatrica Taiwanica, 48(4), 226-232. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper. (2007). Wkly Epidemiol Rec, 82(12), 93-104. Prevention, C. f. D. C. a. (2004). Notice to Readers: Pneumococcal Conjugate Vaccine Shortage Resolved. MMWR Recomm Rep, 53(36), 851-852. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). (1997). MMWR Recomm Rep, 46(RR-8), 1-24. Prosser, L. A., Ray, G. T., O'Brien, M., Kleinman, K., Santoli, J., & Lieu, T. A. (2004). Preferences and willingness to pay for health states prevented by pneumococcal conjugate vaccine. Pediatrics, 113(2), 283. Riedel, S., Beekmann, S., Heilmann, K., Richter, S., Garcia-de-Lomas, J., Ferech, M., et al. (2007). Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases, 26(7), 485-490. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health education monographs, 2(4), 328-335. Salmon, D. A., Sotir, M. J., Pan, W. K., Berg, J. L., Omer, S. B., Stokley, S., et al. (2009). Parental vaccine refusal in Wisconsin: a case-control study. WMJ, 108(1), 17-23. Tickner, S., Leman, P. J., & Woodcock, A. (2010). The Immunisation Beliefs and Intentions Measure (IBIM): Predicting parents' intentions to immunise preschool children. Vaccine, 28(19), 3350-3362. 王志堅、朱夢麟、蕭樑基、李智隆、周振英、馮天霖. (2002). 台灣地區侵襲性肺炎鏈球菌之流行病學調查 (No. DOH91-DC-1011). 李守義, 周碧瑟, & 晏涵文. (1989). 健康信念模式的回顧與前瞻. 中華民國公共衛生學會雜誌, 9(3), 123-137. 周振英、王志堅、朱夢麟. (2004). 台灣地區兒童肺炎鏈球菌之侵襲性感染與帶菌率流行病學調查 (No. DOH93-DC-2023). 周振英、陳英彥、沈姵妏、姚淑滿. (2003). 侵襲性肺炎鏈球菌在台灣地區血清型及分子生物學研究 (No. DOH92-DC-2014). 林奏延等人. (2007). 台灣地區侵襲性肺炎鏈球菌感染流行病學調查 (No. DOH96-DC-1017). 洪光明、吳美珠、季瑋珠. (2000). 板橋市帅兒為接種麻疹疫苗相關因素之探討. 中華民國家庭醫學雜誌, 10(1),1-14. 郎慧珠、藍忠孚. (2001). 假設市場評價法-一種導出付費意願的方法. 公共衛生, 27(4), 261-273. 財團法人李慶雲兒童感染暨疫苗發展醫學文教基金會:感染與疫苗.台北:藝軒.2003. 許淑雲、廖宏恩、洪百薰、林柏煌、高昆裕、王俊毅. (2010). 國小低年級學童家長對其子女接種流感疫苗意向之轉變情形及其相關因素分析-以雲林縣學童家長為例. 台灣衛誌, 29(4), 326-336. 陳宜民. (2003). 預防醫學: 巨流圖書公司. 傅組壇, & 葉寶文. (2005). 應用CVM 在健康效益之評估-高血壓疾病預防之願付價值. 經濟論文叢刊, 33(1), 1-32. 楊玉鳳、黃玉成. (2009). 肺炎鏈球菌與疫苗. 感染控制雜誌, 19(4), 240-246. 資策會. (2011 ). 2010年我國家庭寬頻應用現況與需求調查. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/66115 | - |
dc.description.abstract | 研究背景與目的:台灣疾病管制局於2007年將侵襲性肺炎鏈球菌感染症(Invasive pneumococcal disease, IPD)納為第四類法定傳染病,世界衛生組織認為讓幼童接種肺炎鏈球菌疫苗是較有效預防IPD的介入方案。本研究的目的是探討家長對幼童肺炎鏈球菌疫苗接種之相關因素與願付價值(Willingness-to-pay, WTP)。
研究方法:研究對象為家中有五歲以下幼童之家長,且平時會於網路上搜尋相關醫療資訊者,調查時間為2011年4月20日至5月10日,透過網路問卷的調查方式蒐集有效樣本共566份。以卡方、威爾克森符號等級及克-瓦二氏單因子等級檢定雙因子相關,再以羅吉斯迴歸分析檢定影響家長是否讓小孩接種疫苗的相關因子,最後再以複迴歸分析檢定家長對疫苗的最大願付價值及相關影響因子。 研究結果:幼童肺炎鏈球菌疫苗的接種率約為68%;多數家長對疾病知識有一定程度的了解,但是對於疫苗效價和政府補助方案較不清楚;「疾病知識分數高」、「自覺行動利益高」、「自覺行動非金錢障礙低」、「自覺行動金錢障礙低」、「小孩滿一歲之後」、「家長年齡界於30至34歲」、「曾有醫療人員建議」或「曾看過院所宣傳單」者,較傾向讓小孩接種疫苗;「已讓小孩接種疫苗」或「自覺行動金錢障礙愈低」的家長,其願付價值愈高;家長對幼童肺炎鏈球菌疫苗之最大願付價值皆高於市售價格,其最大願付價值分界於台幣13,325 ~16,103元(幼童年齡0至6個月的家長)、8,576~12,670元(幼童年齡7至11個月的家長)、7,567~10,627元(幼童年齡12至23個月的家長)、2,711~3,128元(幼童年齡二至五歲的家長)。 結論與建議:針對本研究結果,建議衛生主管機關除可加強宣導疫苗方面的訊息,並且擬定相關補助辦法,提高醫療公帄性外,同時鼓勵醫療人員進行預防接種之衛生教育,藉以增加民眾對疫苗資訊的可近性。另一方面,建議未來的研究者可放入更多非醫療相關因素和假設情境之參數,再配合不同輔助工具的詢價方式,檢測家長對幼童肺炎鏈球菌疫苗之最大願付價值。 | zh_TW |
dc.description.abstract | Background and objectives: Invasive pneumococcal disease (IPD) is one of the most commonly seen infectious diseases among children under five years old in Taiwan. This study aimed at analyzing parents’ health beliefs to and assessing willingness-to-pay for pneumococcal vaccination for their children.
Methods: A total of 566 web-based questionnaires were completed by parents who had children under five years old from April 20th to May 10th, 2011. Hypotheses were tested by using Chi-square, Wilcoxon rank sum test and Kruskal-Wallis test. Related factors which were associated with pneumococcal vaccination were examined by using logistic regression. The estimation of respondents’ willingness-to-pay for pneumococcal vaccination was calculated by using multiple linear regression. Results: Study results indicate that 68% of respondents’ children were vaccinated against IPD. Most of the parents understood the knowledge of IPD but few of them realized the information about vaccination. The results showed that parents who understanding IPD more, perceiving more benefits and fewer barriers about vaccination, age between 30 and 34, being suggested by medical staff, seeing the information at hospital, or their children’s age > 1 year old tended to have their children vaccinated. In additon, parents who had let their children vaccinate or perceived lower monetary barriers would pay more for the vaccination. The amount of willingness-to-pay was NT$13,325-16,103 (for parents who had children under 6 months old), NT$8,576-12,670 (for parents who had children 7 to 11 months old), NT$7,567-10,627 (for parents who had children 12 to 23 months old) and NT$2,711-3,128 (for parents who had children 2 to 5 years old). Conclusions: According to the results, the respondents were lacking information about vaccination. The competent authority could not only establish the reward systems to those in need but also motivate the physicians and nurses to educate the recipients. Future researchers could add more parameters along with different tools to aquire price to examine the willingness-to-pay of parents toward pneumococcal vaccination. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T00:22:18Z (GMT). No. of bitstreams: 1 ntu-100-R98843004-1.pdf: 1245726 bytes, checksum: 1c5fcf62e2d8921f675a175bc757bfe4 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 誌謝 ................................................................................................................................. ii
中文摘要 ......................................................................................................................... iii Abstract ............................................................................................................................ iv 第一章 緒論 .................................................................................................................... 1 第一節 研究背景 .................................................................................................... 1 第二節 研究動機 .................................................................................................... 2 第三節 研究目的與重要性 .................................................................................... 2 第二章 文獻探討 ............................................................................................................ 3 第一節 肺炎鏈球菌及疫苗 .................................................................................... 3 第二節 健康信念模式 .......................................................................................... 10 第三節 假設市場評價法 ...................................................................................... 15 第四節 綜合討論 .................................................................................................. 21 第三章 研究方法 .......................................................................................................... 22 第一節 研究架構 .................................................................................................. 22 第二節 研究假說 .................................................................................................. 23 第三節 研究變項與操作型定義 .......................................................................... 24 第四節 研究工具 .................................................................................................. 31 第五節 研究對象與資料蒐集方式 ...................................................................... 32 第六節 資料處理與分析 ...................................................................................... 33 第四章 研究結果 .......................................................................................................... 35 第一節 描述性分析 .............................................................................................. 35 第二節 接種帅童肺炎鏈球疫苗之相關因素 ...................................................... 47 第三節 接種帅童肺炎鏈球菌疫苗之最大願付價值 .......................................... 60 第五章 討論 .................................................................................................................. 68 第一節 資料品質 .................................................................................................. 68 第二節 研究結果討論 .......................................................................................... 70 第三節 假說驗證 .................................................................................................. 74 第四節 研究限制 .................................................................................................. 76 第六章 結論與建議 ...................................................................................................... 77 第一節 結論 .......................................................................................................... 77 第二節 建議 .......................................................................................................... 79 參考文獻 ........................................................................................................................ 81 附錄 ............................................................................................................................... 86 附件一 台灣大學公共衛生學院人體詴驗審查證明書 ...................................... 86 附件二 家長對帅童肺炎鏈球菌疫苗之健康信念與願付價值調查問卷 .......... 87 vii 附件三 行動提示變項與健康信念變項之雙變項分析結果 .............................. 95 附件四 人口變項與健康信念變項之雙變項分析結果 ...................................... 97 | |
dc.language.iso | zh-TW | |
dc.title | 家長對幼童肺炎鏈球菌疫苗接種之健康信念與願付價值 | zh_TW |
dc.title | Parents’ Health Belief to and Willingness-to-Pay for Pneumococcal Vaccination for Their Children | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 郎慧珠,湯澡薰 | |
dc.subject.keyword | 幼童肺炎鏈球菌疫苗,健康信念模式,最大願付價值, | zh_TW |
dc.subject.keyword | pneumococcal vaccination,Health Belief Model,Willingness-to-pay, | en |
dc.relation.page | 102 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-06-13 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
顯示於系所單位: | 健康政策與管理研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 1.22 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。